Variables | pT3 | Gleason 8 or higher | ||||
---|---|---|---|---|---|---|
OR | 95%CI | p value | OR | 95%CI | p value | |
TT (normal vs low) | 1.017 | 0.479–2.159 | 0.965 | 0.484 | 0.237–0.985 | 0.045* |
FT (normal vs low) | 0.587 | 0.374–0.921 | 0.020* | 0.456 | 0.249-0.835 | 0.011* |
Age (continuous) | 1.006 | 0.979–1.034 | 0.665 | 1.006 | 0.979–1.003 | 0.677 |
BMI (continuous) | 1.016 | 0.960–1.076 | 0.581 | 1.014 | 0.960–1.072 | 0.607 |
Diabetes (presence vs absence) | 1.243 | 0.719–2.149 | 0.436 | 0.970 | 0.573–1.641 | 0.909 |
Hypertension (presence vs absence) | 0.855 | 0.472–1.549 | 0.605 | 1.087 | 0.629–1.878 | 0.765 |
Coronary heart disease (presence vs absence) | 1.203 | 0.624–2.322 | 0.581 | 1.279 | 0.683–2.395 | 0.443 |
Smoke (presence vs absence) | 1.280 | 0.723–2.266 | 0.397 | 1.400 | 0.825–2.376 | 0.212 |
Alcohol (presence vs absence) | 0.763 | 0.471–1.236 | 0.272 | 1.428 | 0.924–2.208 | 0.109 |
PSA (≥10 ng/ml vs < 10 ng/ml) | 1.007 | 0.644–1.575 | 0.975 | 1.829 | 1.195–2.800 | 0.005* |
Proportion of free-PSA (≥ 0.16 vs < 0.16) | 0.851 | 0.540–1.340 | 0.486 | 1.030 | 0.664–1.599 | 0.894 |
Clinical Tumor stage (T2a vs T3) | 0.057 | 0.021–0.153 | < 0.001* | 0.439 | 0.212-0.909 | 0.027* |
Clinical (T2b vs T3) | 0.059 | 0.029–0.120 | < 0.001* | 0.454 | 0.258-0.800 | 0.006* |
Clinical (T2c vs T3) | 0.474 | 0.299–0.750 | 0.001* | 0.840 | 0.513-1.374 | 0.487 |
Biopsy Gleason Score (6 vs 8 or higher) | 0.289 | 0.149–0.562 | < 0.001* | 0.179 | 0.093-0.344 | < 0.001* |
Biopsy Gleason Score (7 vs 8 or higher) | 0.800 | 0.500–1.279 | 0.351 | 0.723 | 0.467–1.121 | 0.148 |